THE 21 CENTURY HAS FINALLY BROUGHT THE MUCH NEEDED QUANTUM LEAP IN APPLICABLE TECHNOLOGY FOR IMPROVING PUBLIC HEALTH AND PROVIDING ALTERNATIVE TECHNOLOGY We, the founders of ZEROPIC, are proud to be part of this revolutionary change, which protects beings and nature equally. We take pride in improving public health with preventive and alternative technologies, thus making the world a better, healthier and happier place and ensuring a bright future and healthy environment for future generations. Our Offer to Investors Up to 8% return per year for loans! Value increase of 36.05% at 4 years on your investment with us! For Equity Investments we can offer 3000 Class A preferred shares. Return Repurchase & Stock Dividends
There is a worldwide Problem The Truth and Facts about Vector-Borne Diseases: Vector-borne diseases account for more than 17% of all infectious diseases, causing more than 1 million deaths annually. More than 2.5 billion people in over 100 countries are at risk of contracting dengue alone. Malaria causes more than 400 000 deaths every year globally, most of them children under 5 years of age. 214 Million newly reported cases for Malaria. WHO wants to spend over 8.7 Billion $ to reduce reported Malaria Cases by 90% until 2030 (Cooperation with the pharmaceutical industry and a purely chemical approach)
They fear Thunderstorms! Storms present a significant danger for mosquitoes. As soon as a mosquito s sensilla (hair-like sensory organs) perceive signs of a storm, the insect instinctively changes its behaviour and goes into survival mode. In this state, the mosquito concentrates all its energy on protecting its life and is not able to use its sting mechanism. The ZEROPIC mosquito repellent protector contains a battery-powered high-tech module, which emits an electromagnetic signal in a nanosecond rhythm. The transmitted electromagnetic waves and fields simulate the atmospheric discharges of a storm. The final product may differ in shape and appearance from the product shown on the picture. ZEROPIC is an intelligent, high-tech Mosquito repellent solution inspired by nature. A human protection system that disables Mosquitoes from biting hence protecting beings from vector-borne disease like Malaria and Dengue. The ZEROPIC mosquito repellent has already been successfully tested worldwide by employees and customers. The test results have an efficiency greater than 90%. Vectors are living organisms that can transmit infectious diseases between humans or from animals to humans. Many of these vectors are bloodsucking insects, which ingest disease-producing microorganisms during a blood meal from an infected host (human or animal) and later inject it into a new host during their subsequent blood meal. Mosquitoes are the best known disease vector.
Vector-borne diseases account for more than 17% of all infectious diseases, causing more than 1 million deaths annually Malaria causes more than 400 000 deaths every year globally, most of them children under 5 years of age More than 2.5 billion people in over 100 countries are at risk of contracting dengue alone 214 Million newly reported cases for Malaria Aedes Chikungunya Dengue fever Rift Valley fever Yellow fever Zika Anopheles Malaria Culex Japanese encephalitis Lymphatic filariasis West Nile fever Technology Atmospheric discharges e.g. tempests are generating electromagnetic fields, which can be detected in advance and over a long distance. Tempests and storms are life-threatening events for mosquitoes. Their survival reflex takes over and the thirst for blood becomes second priority. We will develop a high-tech ZEROPIC modular unit, which simulates electromagnetic impulses of an atmospheric discharge and transmits them to the closer environment. This electromagnetic field, harmless for humans, which is recognized by the allure receptor in the mosquito s sensillum, creates a safe zone of approximately 2 or even up to 50 meters around the device. Mosquitoes approaching the safe zone immediately recognize the magnetic field as a threat, initiate their natural escape reflex and do not bite anymore. This is how the ZEROPIC modular unit implanted in the ZEROPIC bracelet (first step) protects people from mosquito bites. The method of ZEROPIC differs from the already existing devices and apps using ultrasonic as mosquito repellent. Ultrasound has been proven useless to prevent mosquito bites. Ultrasound can be only received by the male mosquitoes which don t bite. Female, biting mosquitoes, are without auditory senses.
Technical Details: Protection zone 2 meters LED indicators active, charging request, charge control Connections Micro-USB port to charge the battery (IP67) Operating temperature -20 C to + 55 C Working time 4 days 100% free of DEET chemicals No ultrasonic No hazardous radiation Safe for humans and animals Skin-compatible polymer or leather waterproof up to 1 meter Resistant to vibration and impact Worldwide tested Operates under all climatic conditions Developed in Europe and manufactured in Asia 1 years warranty Market Potential We are talking about a worldwide market potential, a billion project! Insecticides and medicines have been used for years in the fight against mosquitoes and vector-borne diseases, and yet hundreds of thousands of people still die every year from the effects of mosquito bites. Since pathogens are always developing resistance to conventional drugs, the disease cannot be eradicated for now. Drugs also often cause side effects and pesticides not only kill mosquitoes, they also have serious consequences on the environment. Market entry in Asia will be the 1th October 2018! Customers are able to pre-order the product directly on our webpage www.zeropic.org. Pre-order Customers get a 50% discount. The price for end customers will be 48 USD The business model is totally scalable and disruptive, as it connects directly with the consumer during the first year until we are able to change to indirect go-2-market approach. The business model is also asset light, because production capacity is outsourced to China and Hong Kong. By sharing our philosophy and supporting our mission to save hundreds of thousands of human lives every year, you prove your personal commitment to protect beings and nature equally. We take pride in improving public health and alternative technologies, thus making the world a healthier and happier place and ensuring a bright future and healthy environment for future generations. We are looking for investors who claim to make something meaningful out of life. Loan Agreement (10 000-100 000) Equity Investment (100 000-900 000) Loan given by lender 100 000 Annual interest rate 8.00% Term years 4 Compound method yearly Total payback after 4Y 136 048.90 Total interest & profit 36 048.90 Total interest rate 36.05% Maturity / ROI: Price per Share Min. Invest amount Max. Invest amount Offer / Security Return Currency 36 months 300 USD USD 300 000 (= 1000 Shares) USD 900 000 (= 3000 Shares) max. 30% Class A pref. Repurchase & Stock Dividends USD / CHF / EUR
STAN Intertrade & Design - Public Health & Alternative Technology Seestrasse 66, 8700 Küsnacht, +41 44 548 40 48, www.zeropic.org Zürcher Kantonalbank, SWIFT: ZKBKCHZZ80A, Konto: CH15 0070 0110 0066 7306 8 PHAT Group Limited - Public Health & Alternative Technology Room 2103, Futura Plaza, 111 How Ming Street, Kwun Tong, Hong Kong www.phat-group.com - contact@phat-group.com - +41 44 548 40 48 Zürcher Kantonalbank, SWIFT: ZKBKCHZZ80A, Konto: CH15 0070 0110 0066 7306 8